Minimal residual disease after conventional treatment significantly impacts on progression-free survival of patients with follicular lymphoma: the FIL FOLL05 trial (Q44294465)

From Wikidata
Jump to navigation Jump to search
scientific article
edit
Language Label Description Also known as
English
Minimal residual disease after conventional treatment significantly impacts on progression-free survival of patients with follicular lymphoma: the FIL FOLL05 trial
scientific article

    Statements

    Minimal residual disease after conventional treatment significantly impacts on progression-free survival of patients with follicular lymphoma: the FIL FOLL05 trial (English)
    Sara Galimberti
    Elena Ciabatti
    Susanna Grassi
    Francesca Guerrini
    Alessandra Dondi
    Luigi Marcheselli
    Pier Paolo Piccaluga
    Anna Gazzola
    Claudia Mannu
    Luigia Monitillo
    Barbara Mantoan
    Ilaria Del Giudice
    Irene Della Starza
    Marzia Cavalli
    Alessandra Tucci
    Giuseppe Alberto Palumbo
    Luigi Rigacci
    Alessandro Pulsoni
    Carola Boccomini
    Daniele Vallisa
    Giovanni Bertoldero
    Mario Petrini
    14 October 2014
    6398-6405

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit